Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production - Dumont,F.J.; Staruch,M.J.; Fischer,P.; DaSilva,C.; Camacho,R. (J Immunol, 1998)